The Ensign Group, Inc. (ENSG) Stock

The Ensign Group, Inc. (ENSG) is a Healthcare stock trading at $179.03 (as of 2026-08-25), with a market capitalization of $10.43B and a trailing P/E of 27.2. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company operates in two segments, Skilled Services and Real Estate. The company offers skilled services, which include short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; and physical, occupational, and speech therapies and other rehabilitative and healthcare services. It also provides standard services, such as room and board, special nutritional programs, social, recreational, entertainment, and other services. In addition, the company offers senior living, as well as mobile diagnostics services; leases real estate properties; and provides other ancillary services consisting of digital x-ray, ultrasound, electrocardiogram, laboratory, sub-acute, and patient transportation services to people in their homes or at long-term care facilities. As of April 4, 2022, it operated 252 healthcare facilities in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.

Understand The Ensign Group, Inc.: how it makes money

ENSG operates skilled nursing and rehabilitation facilities for post-acute patients, earning revenue from Medicare, Medicaid, and managed-care payers plus property rentals from affiliated senior-housing operations. Most dollars flow through roughly 100 skilled facilities where patient-day census drives revenue, while real estate adds a small, steady rent stream.

Revenue equals skilled-patient-days times a government-set payer rate; the company can grow occupancy and shift mix toward higher-acuity skilled days, but it cannot set prices, so margin expansion depends on scale and clinical quality rather than pricing power.

Revenue by segment (latest quarter)
Skilled Services$1.4B
Real Estate$0.0B

Business quality (Mixed): Growth and scale are real (17% revenue growth, 99-facility platform), but 21% gross and 8.5% operating margins leave little cushion if payer rates compress or utilization dips.

Valuation: At 27× earnings, ENSG trades 8% above the Healthcare Services average (25×).

Bull case

  • Clinical quality as census moat: Eighty-five percent of operations carry four- or five-star ratings (latest_call). In a market where Medicare surveyors and families screen for quality before choosing a facility, this creates a referral and occupancy advantage that is slow for competitors to replicate.
  • 99-site platform, low leverage: Management has acquired 99 operations, building a transition pipeline, while balance-sheet capacity and low debt leave room for further roll-ups (latest_call). A larger facility count improves bargaining leverage with payers and spreads fixed costs.
  • Double-digit top-line trajectory: Quarterly revenue reached $1.4B, up 17% year over year (10-Q). That pace of top-line expansion, underpinned by sequential skilled-payer census gains, shows the acquisition pipeline is converting into real revenue growth.

Bear case

  • Medicaid rate overhang: Management flagged potential Medicaid pressure beyond 2026 (latest_call). If state reimbursement rates tighten, the skilled-nursing revenue base takes a direct hit that occupancy gains alone cannot fully offset.
  • Premium multiple on thin margins: The stock trades at 27.3x earnings versus the 25x Healthcare Services median, an 8% premium (valuation). With operating margin at only 8.5%, a modest revenue miss or cost slip compresses the multiple quickly.
  • Seasonal skilled-mix drag: Summer seasonality can pressure skilled mix and cost absorption in Q2 and Q3 (latest_call). When skilled days dip, the same labor base covers more standard (lower-rate) days, squeezing per-unit economics into peak quarter.
Valuation — source: SEC EDGAR (first-party)
Price$179.03
Market Cap$10.43B
P/E Ratio27.2
EV / EBITDA17.7
Price / Book4.27
Price / Sales1.89
Dividend Yield0.1%
DCF Value (model)$95.69
DCF Upside vs Price-46.6%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$5.06B
Net Margin6.8%
Return on Equity15.5%
Debt / Equity0.06
Current Ratio1.21
Revenue Growth (YoY)18.7%
EPS Growth (YoY)14.1%
Financial Health — source: SEC EDGAR
Altman Z-Score3.65 (safe)
Piotroski F-Score5/9 (moderate)
Valuation vs Sector & Industry
Stock P/E27.2
Sector P/E (Healthcare)21.9
Industry P/E (Healthcare Services)25.4
vs Sector24.2%
vs Industry7.2%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderBlackRock, Inc. ($1.48B)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryHealthcare Services
CEOBarry R. Port
Employees39,300
CountryUS
IPO Date2007-11-09

Related Companies (Healthcare Services; 8 comparable companies)

  • PACS Group, Inc. (PACS)
  • National HealthCare Corporation (NHC)
  • Select Medical Holdings Corporation (SEM)
  • Option Care Health, Inc. (OPCH)
  • Agilon Health, Inc. (AGL)
  • Encompass Health Corporation (EHC)
  • Ardent Health Partners, LLC (ARDT)
  • Acadia Healthcare Company, Inc. (ACHC)
ENSG earnings history · ENSG institutional & insider holders · ENSG KPIs & operating metrics · ENSG financials · ENSG investor presentations & press releases · ENSG SEC filings · ENSG peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-25.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.